Pure Global
NCT06417827

Artificial Intelligence for Mental Health Diagnoses and Treatment Plans: A Protocol for Actors and Patients

Sheba Medical Center·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Diagnosis
Drug/Device/Intervention
SP patients-actors
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Sheba Medical Center
Location
Ramat Gan, Israel
Timeline & enrollment
Phase
N/A
Start date
Dec 12, 2023
End date
Dec 31, 2024
Enrollment
220 participants
Primary outcome

Percent agreement of the diagnosis that provide by the psychiatrist and the AI - SPs (actors) part,Percent agreement of the diagnosis that provide by the psychiatrist and the AI- Patients part

Summary

Artificial intelligence (AI) is becoming prevalent in modern medicine and psychiatry. AI is
 based on a wide variety of computer algorithms classified under machine learning (ML).
 
 The purpose of the present study is to evaluate the potential for mental health diagnosis
 using AI.
 
 In the first part of the study, the AI will conduct an interview with standardized patients
 [SP] (actors) presenting a psychiatric illness. The AI will present a differential diagnosis
 and treatment plan. Immediately afterward, the actors will be interviewed by a
 board-certified psychiatrist, who will also give a differential diagnosis and a treatment
 plan. The results of the AI and psychiatrist will be compared.
 
 In the second part of the study, AI will examine patients coming for consultation by a
 psychiatrist in the inpatient units, outpatient units, or in the emergency room (ER) at Sheba
 Medical center. The AI results will be compered to the psychiatrist diagnosis.

ICD-10 classifications
Mental disorder, not otherwise specifiedUnspecified mental disorderUnspecified organic or symptomatic mental disorderMental and behavioural disordersGeneral psychiatric examination, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06417827
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06417827 through Pure Global AI's free database. This phase not specified trial is sponsored by Sheba Medical Center and is currently Recruiting. The study focuses on Mental Health Diagnosis. Target enrollment is 220 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.